Nexus NeuroTech Ventures
San Francisco, California, United StatesFounded 2023
Nexus NeuroTech Ventures was a brain-focused venture capital firm founded in 2023 in San Francisco, investing in technology-based solutions for neurological and psychiatric disorders. The firm concluded operations on March 31, 2026, and its portfolio was absorbed into Sergey Brin's family office, Bayshore Global Management.
40% of their portfolio is in Healthcare. Average disclosed round size is $41.8M (across 7 rounds with reported amounts).
Portfolio
10
Fund Size
$126M
Top Stage
Seed
Last 12 Mo
3
Team
JL
Jon Lundt
Principal
ER
Edward Ruppel III
Investor
JP
Jordi Parramon
Founder
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
10 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| LLotus Neuro | Unknown | — | Dec 2025 |
 Modulight.Bio | Seed | $12.2M | Nov 2025 |
 Modulight | Seed | — | Nov 2025 |
 Nobi Smart Lamps | Series B | — | Jan 2025 |
| MModulight Biotherapeutics | Seed | $12.2M | Jan 2025 |
 Cala Health | Growth | $50M | Dec 2024 |
 Synapticure | Series A | $25M | Nov 2024 |
 Insightec | Growth | $150M | Jun 2024 |
| EEarliTec Diagnostics | Series B | $21.5M | Apr 2024 |
 EarliPoint Health | Series B | $21.5M | — |
Top Co-Investors
Fresh.fund3 shared
Jibe Ventures3 shared
Secret Chord Ventures3 shared
Action Potential Venture Capital1 shared
Vertex Growth Fund1 shared
Ascension Ventures1 shared
SJF Ventures1 shared
GV1 shared
Triventures1 shared
Lightstone Ventures1 shared
Lux Capital1 shared
Imaginary Ventures1 shared
PEAK6 Strategic Capital1 shared
Redseed1 shared
Nosara Capital1 shared
Phoenix Court Group1 shared
Blu Ventures1 shared
Angelini Ventures1 shared
PMV1 shared
LSP Dementia Fund1 shared
Last updated: 8 September 2026